Cite
HARVARD Citation
Leibowitz, R. et al. (2020). A Retrospective Analysis of the Safety and Activity of Lutetium‐177‐Prostate‐Specific Membrane Antigen Radionuclide Treatment in Older Patients with Metastatic Castration‐Resistant Prostate Cancer. Oncologist. pp. 787-792. [Online].